Trump, Big Pharma trade barbs over drug pricing EOs; BARDA gives Regeneron $350M for Ebola drugs
Tensions between the White House and Big Pharma have ratcheted up after President Donald Trump announced four executive orders targeting the pharmaceutical industry. On Tuesday morning, the president fired off the latest public salvo, while Pfizer CEO Albert Bourla harshly criticized the directives in a call with investors.
Without providing evidence, Trump on Twitter accused pharma companies of airing television ads attacking him and, he says, falsely claim the policies would raise prescription drug prices for seniors. It was not clear to which ad or ads Trump was referring.